Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096p47 | Diabetes and Insulin | IMPE2023

Monogenic diabetes characterization in pediatric population from the last 10 years at Hospital Universitario del Valle, Cali Colombia

Sandoval David , Matallana Audrey Mary

Monogenic diabetes is a group of diabetes subtypes that can be classified as neonatal diabetes and maturity onset diabetes of the young. Here we present 12 confirmed patients for monogenic diabetes at the Hospital Universitario del Valle at Cali, Colombia from 2014 to the present year from our total population of 412 patients with CIE10 diagnosis of diabetes in patients under the age of 18 years of age. Here we documented mutations associated with MODY on the GCK gene for 3 pa...

impe0096ep25 | Diabetes and Insulin | IMPE2023

Glucokinase Gene Variant As A Cause of Mody Diabetes

de Beldjenna Liliana Mejia , Liseth Montaño , Audrey Matallana

Introduction: MODY is a heterogeneous group of monogenic disorders that occurs due to β cell dysfunction. The estimated MODY prevalence is around 1–5% of all diabetes mellitus cases, but it varies depending on the population studied. MODY2 is caused by heterozygous inactivating mutations in the glucokinase (GCK) gene loci 7p13. That result in persistent, stable and mild fasting hyperglycemia, glycosylated hemoglobin alterations. Patients with GCK mu...

impe0096ep20 | Diabetes and Insulin | IMPE2023

FOXP3 Neonatal diabetes, case report

Mary Matallana Audrey , Sandoval David , Lozano Jairo-Andres , Patiño Helen-Carolina

A 37 wk of gestation newborn male from a mother with Gestational diabetes also IUGR, consanguineous parents, with persistent glucose levels around 425 mg/dl since his second postnatal day of life with Birth weight of 1640 grams (SD -4.4) and Birth length 41 centimeters (SD -4.6). A diagnosis of Neonatal Diabetes was made and initially he was treated with intravenous insulin to later be switched to SC insulin, basal-prandial therapy analogues (Lispro 0.5 IU if glucose >250 m...